Hybutimibe/Amlodipine/Atorvastatin Calcium

海博麦布/氨氯地平/阿托伐他汀钙

Report date: 2026/04/13 15:31:34

Base Information

Drug NameHybutimibe/Amlodipine/Atorvastatin Calcium
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNiemann-Pick C1-like protein 1 inhibitorsVoltage-gated calcium channel blockersHMG-CoA reductase inhibitors
TargetsNiemann-Pick C1-like protein 1Voltage-gated calcium channelHMG-CoA reductase
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes HybutimibeAmlodipine BesylateAtorvastatin Calcium Hydrate
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesZhejiang Hisun Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Hisun Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A